François Leteurtre
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents 5
- Virology top 5%
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 14
- DNA Repair Mechanisms 8
- DNA and Nucleic Acid Chemistry 4
- Infectious Diseases top 5%
- Oncology top 10%
- Cancer-related Molecular Pathways 4
-
- Synthesis and Biological Evaluation 5
- Synthesis and biological activity 3
-
- Telomeres, Telomerase, and Senescence 4
- Co-authors
- Yves PommierKurt W. KohnMark R. FesenGlenda KohlhagenAkihiko TanizawaÉliane GluckmanKenneth D. PaullMonroe E. Wall
- Cited by
- ToxicologyVirologyMolecular Biology
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- FranceUnited StatesPoland
In The Last Decade
François Leteurtre
32 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Toxicology 252
- Virology 205
- Molecular Biology 1.1k
- Infectious Diseases 269
- Oncology 355
Countries citing papers authored by François Leteurtre
This map shows the geographic impact of François Leteurtre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Leteurtre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Leteurtre more than expected).
Fields of papers citing papers by François Leteurtre
This network shows the impact of papers produced by François Leteurtre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Leteurtre. The network helps show where François Leteurtre may publish in the future.
Co-authorship network
The 25 scholars most cited alongside François Leteurtre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2021 | 1 | |
| 3 | 2013 | 16 | |
| 4 | 2011 | 70 | |
| 5 | 2011 | 31 | |
| 6 | 2008 | 10 | |
| 7 | 2006 | 81 | |
| 8 | 2003 | 36 | |
| 9 | 2000 | 56 | |
| 10 | 1997 | 56 | |
| 11 | 1995 | 30 | |
| 12 | 1995 | 110 | |
| 13 | 1995 | 41 | |
| 14 | 1995 | 14 | |
| 15 | 1994 | 12 | |
| 16 | 1994 | 64 | |
| 17 | 1994 | 55 | |
| 18 | Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compoundsbreakdown → | 1994 | 292 |
| 19 | 1993 | 40 | |
| 20 | 1993 | 42 |
About François Leteurtre
François Leteurtre is a scholar working on Toxicology, Oncology and Molecular Biology, having authored 32 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (14 papers), DNA Repair Mechanisms (8 papers), Bioactive Compounds and Antitumor Agents (5 papers), Synthesis and Biological Evaluation (5 papers), DNA and Nucleic Acid Chemistry (4 papers), Cancer-related Molecular Pathways (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Toxicology (252 citations), Virology (205 citations) and Molecular Biology (1.1k citations). François Leteurtre has collaborated with scholars based in France, United States and Poland. Frequent co-authors include Yves Pommier, Kurt W. Kohn, Mark R. Fesen, Glenda Kohlhagen, Akihiko Tanizawa, Éliane Gluckman, Kenneth D. Paull, Monroe E. Wall, Mansukh C. Wani and G. Le Roux. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.